Literature DB >> 33067186

Alcoholic hepatitis and metabolic disturbance in female mice: a more tractable model than Nrf2 -/- animals.

Lozan Sheriff1,2, Reenam S Khan1,2, Raquel Saborano1,2, Richard Wilkin1,2, Nguyet-Thin Luu1,2, Ulrich L Gunther3,4, Stefan G Hubscher1,2,5,6, Philip N Newsome1,2, Patricia F Lalor7,2.   

Abstract

Alcoholic hepatitis (AH) is the dramatic acute presentation of alcoholic liver disease, with a 15% mortality rate within 28 days in severe cases. Research into AH has been hampered by the lack of effective and reproducible murine models that can be operated under different regulatory frameworks internationally. The liquid Lieber-deCarli (LdC) diet has been used as a means of ad libitum delivery of alcohol but without any additional insult, and is associated with relatively mild liver injury. The transcription factor nuclear factor-erythroid 2-related factor 2 (Nrf2) protects against oxidative stress, and mice deficient in this molecule are suggested to be more sensitive to alcohol-induced injury. We have established a novel model of AH in mice and compared the nature of liver injury in C57/BL6 wild-type (WT) versus Nrf2 -/- mice. Our data showed that both WT and Nrf2 -/- mice demonstrate robust weight loss, and an increase in serum transaminase, steatosis and hepatic inflammation when exposed to diet and ethanol. This is accompanied by an increase in peripheral blood and hepatic myeloid cell populations, fibrogenic response and compensatory hepatocyte regeneration. We also noted characteristic disturbances in hepatic carbohydrate and lipid metabolism. Importantly, use of Nrf2 -/- mice did not increase hepatic injury responses in our hands, and female WT mice exhibited a more-reproducible response. Thus, we have demonstrated that this simple murine model of AH can be used to induce an injury that recreates many of the key human features of AH - without the need for challenging surgical procedures to administer ethanol. This will be valuable for understanding of the pathogenesis of AH, for testing new therapeutic treatments or devising metabolic approaches to manage patients whilst in medical care.This article has an associated First Person interview with the joint first authors of the paper.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Alcoholic hepatitis; Fibrogenesis; Inflammation; Murine; Steatosis

Year:  2020        PMID: 33067186      PMCID: PMC7790192          DOI: 10.1242/dmm.046383

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  67 in total

1.  Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis.

Authors:  Pau Sancho-Bru; José Altamirano; Daniel Rodrigo-Torres; Mar Coll; Cristina Millán; Juan José Lozano; Rosa Miquel; Vicente Arroyo; Juan Caballería; Pere Ginès; Ramon Bataller
Journal:  Hepatology       Date:  2012-04-23       Impact factor: 17.425

2.  Mallory bodies in experimental animals and man.

Authors:  H Denk; W W Franke; D Kerjaschki; R Eckerstorfer
Journal:  Int Rev Exp Pathol       Date:  1979

3.  A histologic scoring system for prognosis of patients with alcoholic hepatitis.

Authors:  José Altamirano; Rosa Miquel; Aezam Katoonizadeh; Juan G Abraldes; Andrés Duarte-Rojo; Alexandre Louvet; Salvador Augustin; Rajeshwar P Mookerjee; Javier Michelena; Thomas C Smyrk; David Buob; Emmanuelle Leteurtre; Diego Rincón; Pablo Ruiz; Juan Carlos García-Pagán; Carmen Guerrero-Marquez; Patricia D Jones; A Sidney Barritt; Vicente Arroyo; Miquel Bruguera; Rafael Bañares; Pere Ginès; Juan Caballería; Tania Roskams; Frederik Nevens; Rajiv Jalan; Philippe Mathurin; Vijay H Shah; Ramón Bataller
Journal:  Gastroenterology       Date:  2014-01-15       Impact factor: 22.682

4.  The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease.

Authors:  Irina A Kirpich; Wenke Feng; Yuhua Wang; Yanlong Liu; David F Barker; Shirish S Barve; Craig J McClain
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

5.  Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration.

Authors:  Alexander Raven; Wei-Yu Lu; Tak Yung Man; Sofia Ferreira-Gonzalez; Eoghan O'Duibhir; Benjamin J Dwyer; John P Thomson; Richard R Meehan; Roman Bogorad; Victor Koteliansky; Yuri Kotelevtsev; Charles Ffrench-Constant; Luke Boulter; Stuart J Forbes
Journal:  Nature       Date:  2017-07-12       Impact factor: 49.962

6.  Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy.

Authors:  Hong-Min Ni; Benjamin L Woolbright; Jessica Williams; Bryan Copple; Wei Cui; James P Luyendyk; Hartmut Jaeschke; Wen-Xing Ding
Journal:  J Hepatol       Date:  2014-05-09       Impact factor: 25.083

Review 7.  Biological effects of chronic ethanol consumption: a reappraisal of the Lieber-De Carli liquid-diet model with reference to skeletal muscle.

Authors:  V R Preedy; P Duane; T J Peters
Journal:  Alcohol Alcohol       Date:  1988       Impact factor: 2.826

8.  Activation of autophagy attenuates EtOH-LPS-induced hepatic steatosis and injury through MD2 associated TLR4 signaling.

Authors:  Xiaoxia Kong; Ying Yang; Li Ren; Tuo Shao; Fengyuan Li; Cuiqing Zhao; Liming Liu; Hongyu Zhang; Craig J McClain; Wenke Feng
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

9.  Altered methylation and expression of ER-associated degradation factors in long-term alcohol and constitutive ER stress-induced murine hepatic tumors.

Authors:  Hui Han; Jay Hu; Mo Y Lau; Min Feng; Lydia M Petrovic; Cheng Ji
Journal:  Front Genet       Date:  2013-10-31       Impact factor: 4.599

10.  The Mouse Microbiome Is Required for Sex-Specific Diurnal Rhythms of Gene Expression and Metabolism.

Authors:  Benjamin D Weger; Cédric Gobet; Jake Yeung; Eva Martin; Sonia Jimenez; Bertrand Betrisey; Francis Foata; Bernard Berger; Aurélie Balvay; Anne Foussier; Aline Charpagne; Brigitte Boizet-Bonhoure; Chieh Jason Chou; Felix Naef; Frédéric Gachon
Journal:  Cell Metab       Date:  2018-10-18       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.